Product Description: Lefradafiban is an orally active glycoprotein IIb/IIIa receptor antagonist. Lefradafiban can be metabolized to its active form, Fradafiban, a non-peptide GP IIb/IIIa receptor antagonist[1].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C23H25N3O6
References: [1]Akkerhuis KM, et al. Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty. Heart. 2001 Apr;85(4):444-50.
CAS Number: 149503-79-7
Molecular Weight: 439.46
Research Area: Metabolic Disease
Target: Others